Castle biosciences reports first quarter 2022 results

Friendswood, texas--(business wire)--castle biosciences, inc. (nasdaq: cstl), a company improving health through innovative tests that guide patient care, today announced its financial results for the first quarter ended march 31, 2022. “we saw significant progress and execution on our growth initiatives in the first quarter, with record test report volume,” said derek maetzold, president and chief executive officer of castle biosciences. “we remain laser-focused on the execution of our three o
CSTL Ratings Summary
CSTL Quant Ranking